title: The effect of parecoxib on kidney function at laparoscopic hysterectomy.
abstract: Conventional nonsteroidal anti-inflammatory drugs (NSAIDs) have a well-documented nephrotoxic action. Still, there are only few studies that have investigated the nephrotoxicity of cyclo-oxycenase-2-inhibitors during the perioperative period. Thirty patients scheduled for elective laparoscopic hysterectomy were enrolled in this prospective, randomized double-blind study. Patients were randomized into two groups: a saline-treated control group (placebo) and 80 mg parecoxib-treated group (parecoxib). The samples for the analyses of serum and urine were collected at the induction of anesthesia, two hours thereafter, two hours from the end of anesthesia, and on the first postoperative day (POD). S-crea, S-urea, S-cystatin C, S-Na, S-K, U-1mikroglobulin/U-crea, U-GST/U-crea, and U-GST/U-crea were analyzed from the samples. Urine output was measured every hour for the first five hours, and total amount of urine was measured until the first postoperative day. There were no clinical and few statistical significant differences between the two groups in the renal measurements during the study period. The urinary output was also similar in the two groups. A single dose of 80 mg of parecoxib was well tolerated by the kidneys in the short-term perioperative use in patients undergoing laparoscopic hysterectomy with ASA physiological status I-II and age under 60 years.
authors.affiliation: Department of Anesthesiology and Intensive Care, University Hospital of Tampere, Tampere, Finland. pia.puolakka@pshp.fi
authors.forename: Pia A E
authors.initials: PA
authors.lastname: Puolakka
authors.forename: Sirpa
authors.initials: S
authors.lastname: Rintala
authors.forename: Arvi
authors.initials: A
authors.lastname: Yli-Hankala
authors.forename: Tiina
authors.initials: T
authors.lastname: Luukkaala
authors.forename: Aimo
authors.initials: A
authors.lastname: Harmoinen
authors.forename: Leena
authors.initials: L
authors.lastname: Lindgren
authors.forename: Michael G F
authors.initials: MG
authors.lastname: Rorarius
mesh_terms: D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000379:methods*; D007555:Isoxazoles / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects* / Q000502:physiology*; D010535:Laparoscopy; D008875:Middle Aged; D011446:Prospective Studies
chemical_list: D016861:Cyclooxygenase Inhibitors; D007555:Isoxazoles; C409945:parecoxib